Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene.
A cold-passaged (cp) temperature-sensitive (ts) mutant of human respiratory syncytial virus designated RSV cpts-248 was previously derived by random chemical mutagenesis of the non-ts mutant cp-RSV that possesses one or more host range mutations. We previously demonstrated in rodents and seronegative chimpanzees that the cpts-248 virus is more attenuated than cp-RSV and is more stable genetically than previously isolated RSV ts mutants. In the present study, we determined that the acquisition of the ts phenotype and the increased attenuation of the cpts-248 virus are associated with a single nucleotide substitution at nucleotide 10,989 that results in a change in the coding region (amino acid position 831) of the polymerase gene. The identification of this attenuating ts mutation is important because cpts-248 was used as the parent virus for the generation of a number of further attenuated mutants that are currently being evaluated as candidate vaccine strains in clinical trials in infants. Furthermore, technology now exists to rationally design new vaccine candidates by incorporating multiple attenuating mutations, such as the one identified here, into infectious viruses that are genetically stable and appropriately attenuated.
Crowe
J E
JE
Respiratory Viruses Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda MD 20892-0720, USA.
Firestone
C Y
CY
Whitehead
S S
SS
Collins
P L
PL
Murphy
B R
BR
D000818:Animals; D001483:Base Sequence; D002522:Chlorocebus aethiops; D003080:Cold Temperature; D004279:DNA, Viral; D012321:DNA-Directed RNA Polymerases / Q000235:genetics*; D005814:Genes, Viral; D006801:Humans; D008969:Molecular Sequence Data; D016296:Mutagenesis; D010641:Phenotype; D018113:Respiratory Syncytial Virus, Human / Q000201:enzymology* / Q000235:genetics; D014709:Vero Cells; D014764:Viral Proteins / Q000235:genetics*; D014765:Viral Vaccines / Q000235:genetics*
D004279:DNA, Viral; D014764:Viral Proteins; D014765:Viral Vaccines; D012321:DNA-Directed RNA Polymerases